The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[[(2S)-3-[(2S)-2-[[(1R)-4-fluoroindan-1-yl]carbamoyl]pyrrolidin-1-yl]-2-[[(2S)-2-(methylamino)propanoyl]amino]-3-oxo-propyl]carbamoyl]-4-methoxy-benzenesulfonyl fluoride ID: ALA5191180
PubChem CID: 168285264
Max Phase: Preclinical
Molecular Formula: C29H35F2N5O7S
Molecular Weight: 635.69
Associated Items:
Names and Identifiers Canonical SMILES: CN[C@@H](C)C(=O)N[C@@H](CNC(=O)c1cc(S(=O)(=O)F)ccc1OC)C(=O)N1CCC[C@H]1C(=O)N[C@@H]1CCc2c(F)cccc21
Standard InChI: InChI=1S/C29H35F2N5O7S/c1-16(32-2)26(37)35-23(15-33-27(38)20-14-17(44(31,41)42)9-12-25(20)43-3)29(40)36-13-5-8-24(36)28(39)34-22-11-10-18-19(22)6-4-7-21(18)30/h4,6-7,9,12,14,16,22-24,32H,5,8,10-11,13,15H2,1-3H3,(H,33,38)(H,34,39)(H,35,37)/t16-,22+,23-,24-/m0/s1
Standard InChI Key: LXHMLZUEZVWXML-ZFIFVKQDSA-N
Molfile:
RDKit 2D
44 47 0 0 0 0 0 0 0 0999 V2000
14.3144 -22.3671 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.7291 -23.0803 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.1394 -22.3646 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4299 -21.0442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1452 -20.6294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7147 -20.6294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1452 -19.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8604 -21.0442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8604 -21.8695 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5757 -20.6294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2868 -21.0442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0021 -20.6294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7173 -21.0442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0021 -19.8042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.2848 -21.8659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4711 -20.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5727 -22.2747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5706 -23.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8585 -23.5047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2807 -23.5082 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1511 -23.0883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4394 -23.4964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4369 -24.3185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1521 -24.7306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8608 -24.3201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6388 -19.8984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4188 -19.6418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0266 -19.3513 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.0311 -20.1889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9522 -21.0027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7036 -21.3339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8374 -20.0121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2477 -20.7203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0642 -20.7182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4715 -20.0086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0562 -19.2997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.2410 -19.3053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4765 -21.4281 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.0172 -23.4923 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.8116 -21.8629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6197 -22.0289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0273 -21.3116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5761 -24.7311 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5778 -25.5561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
4 6 1 0
5 7 1 1
5 8 1 0
8 9 2 0
8 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
11 15 1 6
16 13 1 0
15 17 1 0
17 18 1 0
18 19 1 0
18 20 2 0
19 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 19 1 0
16 26 1 6
26 27 1 0
26 28 2 0
29 27 1 1
29 30 1 0
30 31 1 0
31 33 1 0
32 29 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 32 1 0
34 38 1 0
22 2 1 0
2 39 1 0
40 41 1 0
41 42 1 0
13 40 1 0
16 42 1 0
25 43 1 0
43 44 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 635.69Molecular Weight (Monoisotopic): 635.2225AlogP: 1.11#Rotatable Bonds: 11Polar Surface Area: 163.01Molecular Species: BASEHBA: 8HBD: 4#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.48CX Basic pKa: 8.60CX LogP: 0.90CX LogD: -0.32Aromatic Rings: 2Heavy Atoms: 44QED Weighted: 0.27Np Likeness Score: -0.71
References 1. Udompholkul P, Baggio C, Gambini L, Alboreggia G, Pellecchia M.. (2021) Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein., 64 (21.0): [PMID:34705456 ] [10.1021/acs.jmedchem.1c01459 ]